Back to mobile site

Biogen Idec (BIIB) Pops on Strong Tecfidera Rx Growth

April 29, 2013 10:10 AM EDT Send to a Friend
Biogen Idec (Nasdaq: BIIB) is ticking higher on the session following an update on Tecfidera (BG-12) performance.

Data out ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login